Literature DB >> 15452344

A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.

Sumito Ogawa1, Jean Lozach, Kristen Jepsen, Dominique Sawka-Verhelle, Valentina Perissi, Roman Sasik, David W Rose, Randall S Johnson, Michael G Rosenfeld, Christopher K Glass.   

Abstract

The nuclear receptor corepressor (NCoR) and the related factor known as silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) are essential components of multiprotein complexes that mediate active repression by unliganded nuclear receptors. Recent studies suggest that NCoR and SMRT can interact with and exert repressive effects on several other classes of DNA-binding transcription factors, but the physiological importance of these interactions has not been established. Here, investigation of endogenous transcriptional programs regulated by NCoR in macrophages reveals that NCoR acts as a transcriptional checkpoint for activator protein (AP)-1-dependent gene networks that regulate diverse biological processes including inflammation, cell migration, and collagen catabolism, with loss of NCoR, resulting in derepression of AP-1 target genes. The NCoR corepressor complex imposes an active block of exchange of c-Jun for c-Jun/c-Fos heterodimers, with targeted deletion of the c-Jun locus, resulting in loss of NCoR complexes from AP-1 target genes under basal conditions. The checkpoint function of NCoR is relieved by signal-dependent phosphorylation of c-Jun, which directs removal of NCoR/HDAC3/TBL1/TBLR1 complexes through recruitment of a specific ubiquitylation complex, as a prerequisite to the default binding of c-Jun/c-Fos heterodimers and transcriptional activation. The requirement for a checkpoint function to achieve the appropriate dynamic range of transcriptional responses to inflammatory signals is likely to be used by other signal-dependent transcription factors that regulate diverse homeostatic and developmental processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452344      PMCID: PMC521940          DOI: 10.1073/pnas.0405786101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2.

Authors:  Jinsong Zhang; Markus Kalkum; Brian T Chait; Robert G Roeder
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 3.  Combinatorial control of gene expression by nuclear receptors and coregulators.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 4.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 5.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

6.  Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Authors:  Taro E Akiyama; Shuichi Sakai; Gilles Lambert; Christopher J Nicol; Kimihiko Matsusue; Satish Pimprale; Ying-Hue Lee; Mercedes Ricote; Christopher K Glass; H Bryan Brewer; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.

Authors:  H Eric Xu; Thomas B Stanley; Valerie G Montana; Millard H Lambert; Barry G Shearer; Jeffery E Cobb; David D McKee; Cristin M Galardi; Kelli D Plunket; Robert T Nolte; Derek J Parks; John T Moore; Steven A Kliewer; Timothy M Willson; Julie B Stimmel
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

8.  Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathways.

Authors:  S Ogawa; M Fujita; Y Ishii; H Tsurukami; M Hirabayashi; K Ikeda; A Orimo; T Hosoi; M Ueda; T Nakamura; Y Ouchi; M Muramatsu; S Inoue
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

9.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

10.  An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation.

Authors:  Günter W Klappacher; Victoria V Lunyak; David B Sykes; Dominique Sawka-Verhelle; Julien Sage; Gyan Brard; Sally D Ngo; Denise Gangadharan; Tyler Jacks; Mark P Kamps; David W Rose; Michael G Rosenfeld; Christopher K Glass
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

View more
  94 in total

Review 1.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

2.  Chameau HAT and DRpd3 HDAC function as antagonistic cofactors of JNK/AP-1-dependent transcription during Drosophila metamorphosis.

Authors:  Benoit Miotto; Thierry Sagnier; Hélène Berenger; Dirk Bohmann; Jacques Pradel; Yacine Graba
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

3.  SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways.

Authors:  Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

4.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

Review 5.  PPARs and molecular mechanisms of transrepression.

Authors:  Mercedes Ricote; Christopher K Glass
Journal:  Biochim Biophys Acta       Date:  2007-03-12

6.  Cooperative regulation in development by SMRT and FOXP1.

Authors:  Kristen Jepsen; Anatoli S Gleiberman; Can Shi; Daniel I Simon; Michael G Rosenfeld
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

7.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

8.  Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation.

Authors:  Wenlai Zhou; Ping Zhu; Jianxun Wang; Gabriel Pascual; Kenneth A Ohgi; Jean Lozach; Christopher K Glass; Michael G Rosenfeld
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

9.  Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.

Authors:  Serena Ghisletti; Wendy Huang; Kristen Jepsen; Chris Benner; Gary Hardiman; Michael G Rosenfeld; Christopher K Glass
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

10.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.